The Fetal Medicine Foundation 18th World Congress in Fetal Medicine, Alicante, Spain
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • Face
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidneys
    • Skeleton
    • Tumors
    • Syndrome
    • Other
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infection
  • Labour / Delivery
  • Maternal conditions
  • Multiple pregnancies
  • Other

cfDNA test

  1. A cse of hydrops fetalis secondary to mosaic Down's syndrome, complicated by myeloproliferative disorder View pdf
  2. Cf-DNA screening for down syndrome and other chromosomal abnormalities in unselected pregnancies View pdf
  3. Cytogenetic confirmation of a positive NIPT result: choice between chorionic villus sampling and amniocentesis View pdf
  4. Determinants for cell-free DNA testing uptake among high risk pregnant women in the city of Barcelona View pdf
  5. Experience in performing microarray-based NIPT technology and obtained results View pdf
  6. Invasive prenatal diagnosis in the era of cell-free fetal DNA View pdf
  7. Maternal serum cfDNA concentration as a predictor of due date in term pregnancies View pdf
  8. Non-invasive prenatal testing for common chromosomal aneuploidies View pdf
  9. Outcome of pregnancies with inconclusive cfDNA test results View pdf
  10. Retrospective study about association between fetal fraction on cell-free DNA testing and development of preeclampsia View pdf
  11. The influence of chromosomal microarray and NIPT on the diagnostic yield in pregnancies without ultrasound anomalies View pdf
  12. Value of non-invasive cell-free fetal DNA testing View pdf
339335413222344835153525350133093369330732213277
© 2019 The Fetal Medicine Foundation